Mixing AstraZeneca and mRNA Vaccines

1/ Protection after two doses The most important decision is to get second dose: stronger + longer lasting protection. Two doses of AZ effective at preventing serious illness from OG Covid-19 + early variants. Early studies show good immune response when Moderna/Pfizer used as second dose. 2/ Protection against new variants Delta variant spreading quickly.

What’s in a number? Let’s discuss vaccine efficacy.

What exactly is vaccine efficacy? Efficacy is a measure of how well a vaccine works in clinical trials – specifically, the percent reduction of disease by comparing two groups – one that receives the vaccine and one that doesn’t, under favourable and tightly controlled settings. However, how one measures efficacy can vary significantly. Within the

NACI AstraZeneca Guidance – Suspend Use in Younger Than Age 55

Small increased risk of rare types of blood clots accompanied with thrombocytopenia (low platelets). Called ‘vaccine-induced prothrombotic immune thrombocytopenia’ or VIPIT. VIPIT is very rare. Initial estimates from Germany were 4 per million. Subsequent Norwegian estimates are 42 per million. Per Science Table estimates: occurring in anywhere from 1 in every 125,000 to 1 in

AstraZeneca Infographic

I have been getting a lot of questions on the AstraZeneca Oxford vaccine, and while data is evolving, here is some information Dr Elisabeth Marnik and I put together on its efficacy and safety. So far, it is very effective in preventing severe illness, hospitalization and death – both from clinical trial data as well